CTおよびMRI用造影剤の市場規模、シェア、動向分析レポート：モダリティ別、製品別、投与経路別、用途別、最終用途別、地域別、セグメント予測、2025年～2030年

CTおよびMRI用造影剤の市場動向：

CTおよびMRI用造影剤の世界市場規模は2024年に62億2,000万米ドルと推定され、2025年から2030年にかけてCAGR 7.81%で成長すると予測されています。

ヨウ素化造影剤に対する需要の増加、慢性疾患の負担増、診断インフラの改善に対する政府機関の関心の高まりが、市場の成長を支えるものと予想されます。いくつかの政府当局は、CTやMRIなどの医療画像へのアクセスを向上させるための取り組みを行っています。

例えば、2024年3月に英国政府が発表したデータによると、地域診断センター（CDC）プログラムは、2021年7月の開始以来、イングランド全土で700万件以上の診断検査、チェック、スキャンを提供していることが明らかになりました。このイニシアチブは24億5,000万米ドルの投資によって支えられており、NHSの歴史上、CTとMRIの能力に対する最も重要な財政的コミットメントを示しています。イングランドでは約155センターが稼動しており、政府は2025年3月までに160センターの開設に注力しています。このような診断施設の拡大への注目の高まりは、市場の成長を促進すると予想されます。

心血管疾患や神経疾患などの慢性疾患の有病率の増加は、CT造影剤やMRI造影剤の需要を促進すると予想されます。これらの造影剤は、脳の構造や異常の可視性を高めるため、神経イメージングにおいて極めて重要です。同様に、心臓画像診断では、これらの造影剤は心臓病の診断と評価に役立ちます。2023年1月にScienceDirectが発表した研究によると、CTスキャンの約50％、MRIスキャンの約40％でヨウ素またはガドリニウムベースの造影剤が使用され、画像のコントラストを向上させ、診断を強化しています。この数字は、神経学的検査では60％に達します。その結果、慢性疾患の有病率の増加により、今後数年間でCTおよびMRI用造影剤の需要が増加すると予想されます。

以下のグラフと表は、世界中で脳腫瘍の発生率が増加していることを示しています。これによると、脳腫瘍および中枢神経系がんの患者の大多数はアジアに集中しています。2045年には、アジアで新たに約2,58,996人の脳腫瘍および中枢神経系がん患者が発生すると予測されています。このように、アジア、欧州、オセアニア、北米、アフリカなどさまざまな地域で脳腫瘍などの神経疾患の発生率が高まっていることから、CT造影剤とMRI造影剤の需要が高まると予想されています。

また、ヨウ素化造影剤の需要増が市場成長を促進すると予測されています。2022年、米国FDAはヨード化造影剤の不足を報告しました。また、2023年8月には、ミズーリ大学医学部の神経学者Adnan Qureshi博士が率いる研究により、ヨウ素系造影剤の不足が米国内の病院における脳卒中患者の評価に大きな影響を及ぼし、この不足によりCT手技が減少したことが判明しました。この不足は、感染症の流行増加と相まって、メーカーに生産能力の強化を促しています。

例えば、GEヘルスケアは2022年11月に8,000万米ドルを投資し、世界の需要に対応するため、ノルウェーの拠点でヨード化造影剤の生産を拡大しました。イオヘキソールおよびヨウジキサノールの原薬は、年間1億人以上の患者投与に使用されるGEのヨード化造影剤に欠かせないです。投資と新たな生産ラインにより、生産能力は2025年までに年間3,000万回分増加すると予想されており、これらの必須分子に対する需要の高まりを浮き彫りにしています。

市場の集中度と特徴

CTおよびMRI用造影剤業界は、慢性疾患の有病率の上昇、生産能力の拡大、ヘルスケア投資の増加により、緩やかな成長段階にあります。

CTおよびMRI用造影剤市場は、技術革新の著しい急増に見舞われています。主な発展には、より安全で効果的な薬剤のための配合強化、より精密な画像化のためのナノテクノロジーの利用、環境への影響を最小限に抑える生分解性薬剤の導入などがあります。例えば、2023年4月、GEヘルスケアはガドリニウムベースのMRI造影剤Pixxoscan（gadobutrol）を発売しました。この造影剤は環境に優しい+PLUSPAKプラスチック包装が特徴で、コストを削減し、環境への影響を最小限に抑え、安全性を高めています。

CTおよびMRI用造影剤市場では、患者の安全性と品質基準を確保するための規制が極めて重要です。米国FDA、欧州連合、その他の地域当局などの規制機関は、CTおよびMRI用造影剤の臨床試験と販売認可を規制しています。例えば、2023年6月、FDAはヨードベースの造影剤イオプロミド注射剤（Ultravist）を静脈内および動脈内造影マンモグラフィ用に承認しました。ウルトラビストはCT検査にも使用されます。このような承認は、予測期間中、CTおよびMRI用造影剤業界を牽引すると予想されます。

CTおよびMRI用造影剤業界の企業は、革新的な代替製品を導入しています。例えば、2024年10月、GEヘルスケアはマンガンベースの大環状MRI造影剤の第I相臨床開発の完了を発表しました。認可されれば、この造影剤はガドリニウムベースの造影剤の代替となり、患者から排泄されるガドリニウムによる環境への影響を軽減することができます。

この業界は、大手企業が世界のプレゼンス向上を目指しているため、かなりの地域的成長を遂げています。例えば、2022年10月、GEヘルスケアのファーマシューティカル・ダイアグノスティックス部門は、チリの鉱山会社Sociedad Quimica y Minera de Chile S.A.（SQM）との長期契約を発表し、世界中のX線検査やCT検査で使用される造影剤に不可欠な成分であるヨウ素の安定供給を確保しました。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 CTおよびMRI用造影剤市場の変数、動向、および範囲

• 市場イントロダクション/系統展望
  • 親市場の見通し
  • 関連/付随市場展望
• 市場力学
  • 市場促進要因分析
  • 市場抑制要因分析
  • 市場機会分析
  • 市場課題分析
• CTおよびMRI用造影剤市場分析ツール
  • ポーター分析
  • PESTEL分析

第4章 CTおよびMRI用造影剤市場：製品別推定・動向分析

• 定義と範囲
• 製品市場シェア、2018年および2030年
• セグメントダッシュボード
• CTおよびMRI用造影剤市場：製品別展望
• 2025年から2030年までの市場規模と予測および動向分析：
  • ガドリニウム造影剤
  • ヨード造影剤

第5章 CTおよびMRI用造影剤市場：モダリティ別推定・動向分析

• 定義と範囲
• モダリティ市場シェア、2024年および2030年
• セグメントダッシュボード
• CTおよびMRI用造影剤市場：モダリティ別展望
• 2018年から2030年までの市場規模と予測および動向分析
  • 磁気共鳴画像法
  • X線/コンピュータ断層撮影

第6章 CTおよびMRI用造影剤市場：用途別推定・動向分析

• 定義と範囲
• 用途別市場シェア、2024年および2030年
• セグメントダッシュボード
• CTおよびMRI用造影剤市場：用途別展望
• 2018年から2030年までの市場規模と予測および動向分析
  • 心血管疾患
  • 神経疾患
  • 胃腸障害
  • がん
  • 腎臓疾患
  • 筋骨格系障害
  • その他

第7章 CTおよびMRI用造影剤市場：投与経路別推定・動向分析

• 定義と範囲
• 投与経路市場シェア、2024年および2030年
• セグメントダッシュボード
• 投与経路別CTおよびMRI用造影剤市場展望
• 2018年から2030年までの市場規模と予測および動向分析
  • 静脈内
  • 経口造影剤
  • 直腸

第8章 CTおよびMRI用造影剤市場：最終用途別推定・動向分析

• 定義と範囲
• 最終用途市場シェア、2024年および2030年
• セグメントダッシュボード
• CTおよびMRI用造影剤市場の最終用途別展望
• 2018年から2030年までの市場規模と予測および動向分析
  • 病院
  • 診断画像センター
  • その他

第9章 CTおよびMRI用造影剤市場：地域別推定・動向分析、製品別

• 地域別市場シェア分析、2024年および2030年
• 地域市場ダッシュボード
• 世界地域市場のスナップショット
• 地域別市場シェアと主要プレーヤー（2024年）
  • 北米
  • 欧州
  • アジア太平洋
  • ラテンアメリカ
  • 中東およびアフリカ
• 市場規模と予測、動向分析（2018～2030年）
• CTおよびMRI用造影剤市場シェア（地域別、2024年および2030年）
• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • 英国
  • ドイツ
  • フランス
  • イタリア
  • スペイン
  • デンマーク
  • スウェーデン
  • ノルウェー
• アジア太平洋
  • 中国
  • インド
  • 日本
  • 韓国
  • タイ
  • オーストラリア
• ラテンアメリカ
  • ブラジル
  • アルゼンチン
• 中東およびアフリカ
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦
  • クウェート

第10章 競合情勢

• 主要市場参入企業による最近の動向と影響分析
• 企業/競合の分類
• ベンダー情勢
• 主要企業プロファイル
  • Bayer
  • GE Healthcare
  • Guerbet
  • Bracco Diagnostics Inc
  • Fresenius Kabi

List of Tables

• Table 1 List of Secondary Sources
• Table 2 List of Abbreviations
• Table 3 Global CT and MRI Contrast Agents Market, by Region, 2018 - 2030 (USD Million)
• Table 4 Global CT and MRI Contrast Agents Market, by Product, 2018 - 2030 (USD Million)
• Table 5 Global CT and MRI Contrast Agents Market, by Modality, 2018 - 2030 (USD Million)
• Table 6 Global CT and MRI Contrast Agents Market, by Application, 2018 - 2030 (USD Million)
• Table 7 Global CT and MRI Contrast Agents Market, by End Use, 2018 - 2030 (USD Million)
• Table 8 Global CT and MRI Contrast Agents Market, by Route of Administration, 2018 - 2030 (USD Million)
• Table 9 North America CT and MRI Contrast Agents Market, by Country, 2018 - 2030 (USD Million)
• Table 10 North America CT and MRI Contrast Agents Market, by Product, 2018 - 2030 (USD Million)
• Table 11 North America CT and MRI Contrast Agents Market, by Modality, 2018 - 2030 (USD Million)
• Table 12 North America CT and MRI Contrast Agents Market, by Application, 2018 - 2030 (USD Million)
• Table 13 North America CT and MRI Contrast Agents Market, by End Use, 2018 - 2030 (USD Million)
• Table 14 North America CT and MRI Contrast Agents Market, by Route of Administration, 2018 - 2030 (USD Million)
• Table 15 U.S. CT and MRI Contrast Agents Market, by Product, 2018 - 2030 (USD Million)
• Table 16 U.S. CT and MRI Contrast Agents Market, by Modality, 2018 - 2030 (USD Million)
• Table 17 U.S. CT and MRI Contrast Agents Market, by Application, 2018 - 2030 (USD Million)
• Table 18 U.S. CT and MRI Contrast Agents Market, by End Use, 2018 - 2030 (USD Million)
• Table 19 U.S. CT and MRI Contrast Agents Market, by Route of Administration, 2018 - 2030 (USD Million)
• Table 20 Canada CT and MRI Contrast Agents Market, by Product, 2018 - 2030 (USD Million)
• Table 21 Canada CT and MRI Contrast Agents Market, by Modality, 2018 - 2030 (USD Million)
• Table 22 Canada CT and MRI Contrast Agents Market, by Application, 2018 - 2030 (USD Million)
• Table 23 Canada CT and MRI Contrast Agents Market, by End Use, 2018 - 2030 (USD Million)
• Table 24 Canada CT and MRI Contrast Agents Market, by Route of Administration, 2018 - 2030 (USD Million)
• Table 25 Mexico CT and MRI Contrast Agents Market, by Product, 2018 - 2030 (USD Million)
• Table 26 Mexico CT and MRI Contrast Agents Market, by Modality, 2018 - 2030 (USD Million)
• Table 27 Mexico CT and MRI Contrast Agents Market, by Application, 2018 - 2030 (USD Million)
• Table 28 Mexico CT and MRI Contrast Agents Market, by End Use, 2018 - 2030 (USD Million)
• Table 29 Mexico CT and MRI Contrast Agents Market, by Route of Administration, 2018 - 2030 (USD Million)
• Table 30 Europe CT and MRI Contrast Agents Market, by Country, 2018 - 2030 (USD Million)
• Table 31 Europe CT and MRI Contrast Agents Market, by Product, 2018 - 2030 (USD Million)
• Table 32 Europe CT and MRI Contrast Agents Market, by Modality, 2018 - 2030 (USD Million)
• Table 33 Europe CT and MRI Contrast Agents Market, by Application, 2018 - 2030 (USD Million)
• Table 34 Europe CT and MRI Contrast Agents Market, by End Use, 2018 - 2030 (USD Million)
• Table 35 Europe CT and MRI Contrast Agents Market, by Route of Administration, 2018 - 2030 (USD Million)
• Table 36 UK CT and MRI Contrast Agents Market, by Product, 2018 - 2030 (USD Million)
• Table 37 UK CT and MRI Contrast Agents Market, by Modality, 2018 - 2030 (USD Million)
• Table 38 UK CT and MRI Contrast Agents Market, by Application, 2018 - 2030 (USD Million)
• Table 39 UK CT and MRI Contrast Agents Market, by End Use, 2018 - 2030 (USD Million)
• Table 40 UK CT and MRI Contrast Agents Market, by Route of Administration, 2018 - 2030 (USD Million)
• Table 41 Germany CT and MRI Contrast Agents Market, by Product, 2018 - 2030 (USD Million)
• Table 42 Germany CT and MRI Contrast Agents Market, by Modality, 2018 - 2030 (USD Million)
• Table 43 Germany CT and MRI Contrast Agents Market, by Application, 2018 - 2030 (USD Million)
• Table 44 Germany CT and MRI Contrast Agents Market, by End Use, 2018 - 2030 (USD Million)
• Table 45 Germany CT and MRI Contrast Agents Market, by Route of Administration, 2018 - 2030 (USD Million)
• Table 46 France CT and MRI Contrast Agents Market, by Product, 2018 - 2030 (USD Million)
• Table 47 France CT and MRI Contrast Agents Market, by Modality, 2018 - 2030 (USD Million)
• Table 48 France CT and MRI Contrast Agents Market, by Application, 2018 - 2030 (USD Million)
• Table 49 France CT and MRI Contrast Agents Market, by End Use, 2018 - 2030 (USD Million)
• Table 50 France CT and MRI Contrast Agents Market, by Route of Administration, 2018 - 2030 (USD Million)
• Table 51 Italy CT and MRI Contrast Agents Market, by Product, 2018 - 2030 (USD Million)
• Table 52 Italy CT and MRI Contrast Agents Market, by Modality, 2018 - 2030 (USD Million)
• Table 53 Italy CT and MRI Contrast Agents Market, by Application, 2018 - 2030 (USD Million)
• Table 54 Italy CT and MRI Contrast Agents Market, by End Use, 2018 - 2030 (USD Million)
• Table 55 Italy CT and MRI Contrast Agents Market, by Route of Administration, 2018 - 2030 (USD Million)
• Table 56 Spain CT and MRI Contrast Agents Market, by Product, 2018 - 2030 (USD Million)
• Table 57 Spain CT and MRI Contrast Agents Market, by Modality, 2018 - 2030 (USD Million)
• Table 58 Spain CT and MRI Contrast Agents Market, by Application, 2018 - 2030 (USD Million)
• Table 59 Spain CT and MRI Contrast Agents Market, by End Use, 2018 - 2030 (USD Million)
• Table 60 Spain CT and MRI Contrast Agents Market, by Route of Administration, 2018 - 2030 (USD Million)
• Table 61 Denmark CT and MRI Contrast Agents Market, by Product, 2018 - 2030 (USD Million)
• Table 62 Denmark CT and MRI Contrast Agents Market, by Modality, 2018 - 2030 (USD Million)
• Table 63 Denmark CT and MRI Contrast Agents Market, by Application, 2018 - 2030 (USD Million)
• Table 64 Denmark CT and MRI Contrast Agents Market, by End Use, 2018 - 2030 (USD Million)
• Table 65 Denmark CT and MRI Contrast Agents Market, by Route of Administration, 2018 - 2030 (USD Million)
• Table 66 Sweden CT and MRI Contrast Agents Market, by Product, 2018 - 2030 (USD Million)
• Table 67 Sweden CT and MRI Contrast Agents Market, by Modality, 2018 - 2030 (USD Million)
• Table 68 Sweden CT and MRI Contrast Agents Market, by Application, 2018 - 2030 (USD Million)
• Table 69 Sweden CT and MRI Contrast Agents Market, by End Use, 2018 - 2030 (USD Million)
• Table 70 Sweden CT and MRI Contrast Agents Market, by Route of Administration, 2018 - 2030 (USD Million)
• Table 71 Norway CT and MRI Contrast Agents Market, by Product, 2018 - 2030 (USD Million)
• Table 72 Norway CT and MRI Contrast Agents Market, by Modality, 2018 - 2030 (USD Million)
• Table 73 Norway CT and MRI Contrast Agents Market, by Application, 2018 - 2030 (USD Million)
• Table 74 Norway CT and MRI Contrast Agents Market, by End Use, 2018 - 2030 (USD Million)
• Table 75 Norway CT and MRI Contrast Agents Market, by Route of Administration, 2018 - 2030 (USD Million)
• Table 76 Asia Pacific CT and MRI Contrast Agents Market, by Country, 2018 - 2030 (USD Million)
• Table 77 Asia Pacific CT and MRI Contrast Agents Market, by Product, 2018 - 2030 (USD Million)
• Table 78 Asia Pacific CT and MRI Contrast Agents Market, by Modality, 2018 - 2030 (USD Million)
• Table 79 Asia Pacific CT and MRI Contrast Agents Market, by Application, 2018 - 2030 (USD Million)
• Table 80 Asia Pacific CT and MRI Contrast Agents Market, by End Use, 2018 - 2030 (USD Million)
• Table 81 Asia Pacific CT and MRI Contrast Agents Market, by Route of Administration, 2018 - 2030 (USD Million)
• Table 82 China CT and MRI Contrast Agents Market, by Product, 2018 - 2030 (USD Million)
• Table 83 China CT and MRI Contrast Agents Market, by Modality, 2018 - 2030 (USD Million)
• Table 84 China CT and MRI Contrast Agents Market, by Application, 2018 - 2030 (USD Million)
• Table 85 China CT and MRI Contrast Agents Market, by End Use, 2018 - 2030 (USD Million)
• Table 86 China CT and MRI Contrast Agents Market, by Route of Administration, 2018 - 2030 (USD Million)
• Table 87 Japan CT and MRI Contrast Agents Market, by Product, 2018 - 2030 (USD Million)
• Table 88 Japan CT and MRI Contrast Agents Market, by Modality, 2018 - 2030 (USD Million)
• Table 89 Japan CT and MRI Contrast Agents Market, by Application, 2018 - 2030 (USD Million)
• Table 90 Japan CT and MRI Contrast Agents Market, by End Use, 2018 - 2030 (USD Million)
• Table 91 Japan CT and MRI Contrast Agents Market, by Route of Administration, 2018 - 2030 (USD Million)
• Table 92 India CT and MRI Contrast Agents Market, by Product, 2018 - 2030 (USD Million)
• Table 93 India CT and MRI Contrast Agents Market, by Modality, 2018 - 2030 (USD Million)
• Table 94 India CT and MRI Contrast Agents Market, by Application, 2018 - 2030 (USD Million)
• Table 95 India CT and MRI Contrast Agents Market, by End Use, 2018 - 2030 (USD Million)
• Table 96 India CT and MRI Contrast Agents Market, by Route of Administration, 2018 - 2030 (USD Million)
• Table 97 South Korea CT and MRI Contrast Agents Market, by Product, 2018 - 2030 (USD Million)
• Table 98 South Korea CT and MRI Contrast Agents Market, by Modality, 2018 - 2030 (USD Million)
• Table 99 South Korea CT and MRI Contrast Agents Market, by Application, 2018 - 2030 (USD Million)
• Table 100 South Korea CT and MRI Contrast Agents Market, by End Use, 2018 - 2030 (USD Million)
• Table 101 South Korea CT and MRI Contrast Agents Market, by Route of Administration, 2018 - 2030 (USD Million)
• Table 102 Australia CT and MRI Contrast Agents Market, by Product, 2018 - 2030 (USD Million)
• Table 103 Australia CT and MRI Contrast Agents Market, by Modality, 2018 - 2030 (USD Million)
• Table 104 Australia CT and MRI Contrast Agents Market, by Application, 2018 - 2030 (USD Million)
• Table 105 Australia CT and MRI Contrast Agents Market, by End Use, 2018 - 2030 (USD Million)
• Table 106 Australia CT and MRI Contrast Agents Market, by Route of Administration, 2018 - 2030 (USD Million)
• Table 107 Thailand CT and MRI Contrast Agents Market, by Product, 2018 - 2030 (USD Million)
• Table 108 Thailand CT and MRI Contrast Agents Market, by Product, 2018 - 2030 (USD Million)
• Table 109 Thailand CT and MRI Contrast Agents Market, by Modality, 2018 - 2030 (USD Million)
• Table 110 Thailand CT and MRI Contrast Agents Market, by Application, 2018 - 2030 (USD Million)
• Table 111 Thailand CT and MRI Contrast Agents Market, by End Use, 2018 - 2030 (USD Million)
• Table 112 Thailand CT and MRI Contrast Agents Market, by Route of Administration, 2018 - 2030 (USD Million)
• Table 113 Latin America CT and MRI Contrast Agents Market, by Country, 2018 - 2030 (USD Million)
• Table 114 Latin America CT and MRI Contrast Agents Market, by Product, 2018 - 2030 (USD Million)
• Table 115 Latin America CT and MRI Contrast Agents Market, by Product, 2018 - 2030 (USD Million)
• Table 116 Latin America CT and MRI Contrast Agents Market, by Modality, 2018 - 2030 (USD Million)
• Table 117 Latin America CT and MRI Contrast Agents Market, by Application, 2018 - 2030 (USD Million)
• Table 118 Latin America CT and MRI Contrast Agents Market, by End Use, 2018 - 2030 (USD Million)
• Table 119 Latin America CT and MRI Contrast Agents Market, by Route of Administration, 2018 - 2030 (USD Million)
• Table 120 Brazil CT and MRI Contrast Agents Market, by Product, 2018 - 2030 (USD Million)
• Table 121 Brazil CT and MRI Contrast Agents Market, by Modality, 2018 - 2030 (USD Million)
• Table 122 Brazil CT and MRI Contrast Agents Market, by Application, 2018 - 2030 (USD Million)
• Table 123 Brazil CT and MRI Contrast Agents Market, by End Use, 2018 - 2030 (USD Million)
• Table 124 Brazil CT and MRI Contrast Agents Market, by Route of Administration, 2018 - 2030 (USD Million)
• Table 125 Argentina CT and MRI Contrast Agents Market, by Product, 2018 - 2030 (USD Million)
• Table 126 Argentina CT and MRI Contrast Agents Market, by Modality, 2018 - 2030 (USD Million)
• Table 127 Argentina CT and MRI Contrast Agents Market, by Application, 2018 - 2030 (USD Million)
• Table 128 Argentina CT and MRI Contrast Agents Market, by End Use, 2018 - 2030 (USD Million)
• Table 129 Argentina CT and MRI Contrast Agents Market, by Route of Administration, 2018 - 2030 (USD Million)
• Table 130 MEA CT and MRI Contrast Agents Market, by Country, 2018 - 2030 (USD Million)
• Table 131 MEA CT and MRI Contrast Agents Market, by Product, 2018 - 2030 (USD Million)
• Table 132 MEA CT and MRI Contrast Agents Market, by Modality, 2018 - 2030 (USD Million)
• Table 133 MEA CT and MRI Contrast Agents Market, by Application, 2018 - 2030 (USD Million)
• Table 134 MEA CT and MRI Contrast Agents Market, by End Use, 2018 - 2030 (USD Million)
• Table 135 MEA CT and MRI Contrast Agents Market, by Route of Administration, 2018 - 2030 (USD Million)
• Table 136 South Africa CT and MRI Contrast Agents Market, by Product, 2018 - 2030 (USD Million)
• Table 137 South Africa CT and MRI Contrast Agents Market, by Modality, 2018 - 2030 (USD Million)
• Table 138 South Africa CT and MRI Contrast Agents Market, by Application, 2018 - 2030 (USD Million)
• Table 139 South Africa CT and MRI Contrast Agents Market, by End Use, 2018 - 2030 (USD Million)
• Table 140 South Africa CT and MRI Contrast Agents Market, by Route of Administration, 2018 - 2030 (USD Million)
• Table 141 Saudi Arabia CT and MRI Contrast Agents Market, by Product, 2018 - 2030 (USD Million)
• Table 142 Saudi Arabia CT and MRI Contrast Agents Market, by Modality, 2018 - 2030 (USD Million)
• Table 143 Saudi Arabia CT and MRI Contrast Agents Market, by Application, 2018 - 2030 (USD Million)
• Table 144 Saudi Arabia CT and MRI Contrast Agents Market, by End Use, 2018 - 2030 (USD Million)
• Table 145 Saudi Arabia CT and MRI Contrast Agents Market, by Route of Administration, 2018 - 2030 (USD Million)
• Table 146 UAE CT and MRI Contrast Agents Market, by Product, 2018 - 2030 (USD Million)
• Table 147 UAE CT and MRI Contrast Agents Market, by Modality, 2018 - 2030 (USD Million)
• Table 148 UAE CT and MRI Contrast Agents Market, by Application, 2018 - 2030 (USD Million)
• Table 149 UAE CT and MRI Contrast Agents Market, by End Use, 2018 - 2030 (USD Million)
• Table 150 UAE CT and MRI Contrast Agents Market, by Route of Administration, 2018 - 2030 (USD Million)
• Table 151 Kuwait CT and MRI Contrast Agents Market, by Product, 2018 - 2030 (USD Million)
• Table 152 Kuwait CT and MRI Contrast Agents Market, by Modality, 2018 - 2030 (USD Million)
• Table 153 Kuwait CT and MRI Contrast Agents Market, by Application, 2018 - 2030 (USD Million)
• Table 154 Kuwait CT and MRI Contrast Agents Market, by End Use, 2018 - 2030 (USD Million)
• Table 155 Kuwait CT and MRI Contrast Agents Market, by Route of Administration, 2018 - 2030 (USD Million)
• Table 156 Participant's Overview
• Table 157 Financial Performance
• Table 158 Product Benchmarking
• Table 159 Strategic Initiatives

List of Figures

• Fig. 1 Information Procurement
• Fig. 2 Primary Research Pattern
• Fig. 3 Market Research Approaches
• Fig. 4 Value Chain-Based Sizing & Forecasting
• Fig. 5 Market Formulation & Validation
• Fig. 6 CT and MRI Contrast Agents Market, Market Segmentation
• Fig. 7 Market Driver Analysis (Current & Future Impact)
• Fig. 8 Market Restraint Analysis (Current & Future Impact)
• Fig. 9 Market Opportunity Analysis (Current & Future Impact)
• Fig. 10 Market Challenge Analysis (Current & Future Impact)
• Fig. 11 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
• Fig. 12 Porter's Five Forces Analysis
• Fig. 13 Global CT and MRI contrast media market: Product movement Analysis
• Fig. 14 Gadolinium-based contrast media market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 15 Iodinated contrast media market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 16 Global CT and MRI contrast media market: Modality movement Analysis
• Fig. 17 Magnetic resonance imaging market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 18 X-ray/computed tomography market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 19 Global CT and MRI contrast media market: Application movement Analysis
• Fig. 20 Cardiovascular disorders market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 21 Neurological disorders market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 22 Gastrointestinal disorders market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 23 Cancer market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 24 Nephrological disorders market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 25 Musculoskeletal disorders market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 26 Global CT and MRI contrast media market: Route of administration movement Analysis
• Fig. 27 Intravenous market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 28 Oral contrast media market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 29 Rectal contrast media market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 30 Global CT and MRI contrast media market: End use movement Analysis
• Fig. 31 Hospitals market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 32 Diagnostic imaging centers contrast media market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 33 Others market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 34 Regional Outlook, 2024 & 2030
• Fig. 35 North America CT and MRI Contrast Agents Market, 2018 - 2030 (USD Million)
• Fig. 36 U.S. CT and MRI Contrast Agents Market, 2018 - 2030 (USD Million)
• Fig. 37 Canada CT and MRI Contrast Agents Market, 2018 - 2030 (USD Million)
• Fig. 38 Mexico CT and MRI Contrast Agents Market, 2018 - 2030 (USD Million)
• Fig. 39 Europe CT and MRI Contrast Agents Market, 2018 - 2030 (USD Million)
• Fig. 40 Germany CT and MRI Contrast Agents Market, 2018 - 2030 (USD Million)
• Fig. 41 UK CT and MRI Contrast Agents Market, 2018 - 2030 (USD Million)
• Fig. 42 France CT and MRI Contrast Agents Market, 2018 - 2030 (USD Million)
• Fig. 43 Italy CT and MRI Contrast Agents Market, 2018 - 2030 (USD Million)
• Fig. 44 Spain CT and MRI Contrast Agents Market, 2018 - 2030 (USD Million)
• Fig. 45 Denmark CT and MRI Contrast Agents Market, 2018 - 2030 (USD Million)
• Fig. 46 Sweden CT and MRI Contrast Agents Market, 2018 - 2030 (USD Million)
• Fig. 47 Norway CT and MRI Contrast Agents Market, 2018 - 2030 (USD Million)
• Fig. 48 Asia Pacific CT and MRI Contrast Agents Market, 2018 - 2030 (USD Million)
• Fig. 49 Japan CT and MRI Contrast Agents Market, 2018 - 2030 (USD Million)
• Fig. 50 China CT and MRI Contrast Agents Market, 2018 - 2030 (USD Million)
• Fig. 51 India CT and MRI Contrast Agents Market, 2018 - 2030 (USD Million)
• Fig. 52 Australia CT and MRI Contrast Agents Market, 2018 - 2030 (USD Million)
• Fig. 53 South Korea CT and MRI Contrast Agents Market, 2018 - 2030 (USD Million)
• Fig. 54 Thailand CT and MRI Contrast Agents Market, 2018 - 2030 (USD Million)
• Fig. 55 Latin America CT and MRI Contrast Agents Market, 2018 - 2030 (USD Million)
• Fig. 56 Brazil CT and MRI Contrast Agents Market, 2018 - 2030 (USD Million)
• Fig. 57 Argentina CT and MRI Contrast Agents Market, 2018 - 2030 (USD Million)
• Fig. 58 Middle East and Africa CT and MRI Contrast Agents Market, 2018 - 2030 (USD Million)
• Fig. 59 South Africa CT and MRI Contrast Agents Market, 2018 - 2030 (USD Million)
• Fig. 60 Saudi Arabia CT and MRI Contrast Agents Market, 2018 - 2030 (USD Million)
• Fig. 61 UAE CT and MRI Contrast Agents Market, 2018 - 2030 (USD Million)
• Fig. 62 Kuwait CT and MRI Contrast Agents Market, 2018 - 2030 (USD Million)

CT And MRI Contrast Agents Market Trends:

The global CT and MRI contrast agents market size was estimated at USD 6.22 billion in 2024 and is anticipated to grow at a CAGR of 7.81% from 2025 to 2030. The increasing demand for iodinated contrast media, the rising burden of chronic disorders, and the rising focus of government bodies on improving diagnostic infrastructure are anticipated to support the market growth. Several government authorities are undertaking initiatives to increase access to medical imaging such as CT and MRI.

For instance, in March 2024, data published by the UK government revealed that the Community Diagnostic Centre (CDC) program has provided over 7 million diagnostic tests, checks, and scans across England since its launch in July 2021. This initiative is supported by an investment of USD 2.45 billion, marking the most significant financial commitment to CT and MRI capacity in the history of the NHS. Around 155 centres are operational in England, and the government is focused on opening 160 centres by March 2025. This growing focus on expanding diagnostic facilities is expected to drive market growth.

The increasing prevalence of chronic conditions, such as cardiovascular and neurological disorders, is expected to drive the demand for CT and MRI contrast agents. These agents are crucial in neurological imaging as they enhance the visibility of brain structures and abnormalities. Similarly, in cardiac imaging, these agents aid in diagnosing and assessing heart disease. According to a study published by ScienceDirect in January 2023, approximately 50% of CT scans and 40% of MRI scans utilize iodine or gadolinium-based contrast agents to improve image contrast and enhance diagnostics. This figure rises to 60% for neurological examinations. As a result, the growing prevalence of chronic disorders is expected to increase the demand for CT and MRI contrast agents in the coming years.

The below graph and table highlight the increasing incidence of brain tumors across the globe. It shows that the majority of individuals with brain and CNS cancer are in Asia. Around 2,58,996 new brain and CNS cancer cases are anticipated in Asia in 2045. Thus, the growing incidence of neurological conditions such as brain tumors across various regions such as Asia, Europe, Oceania, North America, and Africa is anticipated to boost the demand for CT and MRI contrast agents.

In addition, the increasing demand for iodinated contrast media is projected to propel the market growth. In 2022, the U.S. FDA reported the shortage of iodinated contrast media. In addition, in August 2023, a study led by University of Missouri School of Medicine neurologist Dr. Adnan Qureshi found that the iodinated contrast dye shortage had a significant impact on the assessment of stroke patients at hospitals across the U.S. This shortage resulted in a decline in CT procedures. This shortage, coupled with the rising prevalence of infectious diseases, has prompted manufacturers to enhance production capacities.

For instance, GE Healthcare invested USD 80 million in November 2022 to expand iodinated contrast media production at its site in Norway, aiming to meet global demand. Iohexol and iodixanol APIs are crucial in GE's iodinated contrast media, used in over 100 million patient doses annually-equivalent to three procedures every second. With investments and new production lines, the production capacity is anticipated to increase by 30 million doses per year by 2025, highlighting the growing demand for these essential molecules.

Market Concentration & Characteristics

The CT and MRI contrast agents industry is in a moderate growth stage, driven by the rising prevalence of chronic disorders, growing production capacities, and increasing healthcare investments.

The CT and MRI contrast agents market is experiencing a significant surge in innovation. Key developments include enhanced formulations for safer and more effective agents, using nanotechnology for more precise imaging, and introducing biodegradable agents that minimize environmental impact. For instance, in April 2023, GE HealthCare launched Pixxoscan (gadobutrol), a gadolinium-based MRI contrast agent featuring eco-friendly +PLUSPAK plastic packaging that reduces costs, minimizes environmental impact, and enhances safety.

Regulations are crucial in the CT and MRI contrast agents market, ensuring patient safety and quality standards. Regulatory bodies such as the U.S. FDA, the European Union, and other regional authorities regulate clinical trials and marketing authorization for CT and MRI contrast agents. For instance, in June 2023, the FDA approved the iodine-based contrast agent iopromide injection (Ultravist) for intravenous and intraarterial contrast-enhanced mammography. Ultravist is also used in CT procedures. Such approvals are anticipated to drive the CT and MRI contrast agents industry over the forecast period.

Companies in the CT and MRI contrast agents industry are introducing innovative substitute products. For instance, in October 2024, GE Healthcare announced the completion of its Phase I clinical development for a manganese-based macrocyclic MRI contrast agent. If authorized, this agent could act as an alternative to gadolinium-based contrast agents and mitigate the environmental impact of gadolinium excreted by patients.

The industry is undergoing considerable regional growth as major players aim to enhance their global presence. For instance, in October 2022, GE Healthcare's Pharmaceutical Diagnostics division announced a long-term agreement with Chilean mining company Sociedad Quimica y Minera de Chile S.A. (SQM), to ensure a stable supply of iodine, a crucial component for contrast media used in X-ray and CT procedures worldwide.

Global CT And MRI Contrast Agents Market Report Segmentation

This report forecasts revenue & volume growth of the CT and MRI Contrast Agents market and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global agrochemicals market report based on product, modality, application, route of administration, end-use, and region:

• Product Outlook (Revenue, USD Million, 2018 - 2030)
• Gadolinium-based Contrast Media
• Iodinated Contrast Media
• Modality Outlook (Revenue, USD Million, 2018 - 2030)
• Magnetic Resonance Imaging
  • Elucirem/ Vueway
  • Dotarem
  • ProHance
  • MultiHance
  • Gadovist
  • Eovist / Primovist
  • Clariscan
  • Other Generics
• X-ray/ Computed Tomography
  • Optiray
  • ISOVUE
  • Ultravist
  • Omnipaque
  • Visipaque
  • Other Generics
• Application Outlook (Revenue, USD Million, 2018 - 2030)
• Cardiovascular Disorders
• Neurological Disorders
• Gastrointestinal Disorders
• Cancer
• Nephrological Disorders
• Musculoskeletal Disorders
• Others
• Route of Administration Outlook (Revenue, USD Million, 2018 - 2030)
• Intravenous
• Oral Route
• Rectal Route
• End-use Outlook (Revenue, USD Million, 2018 - 2030)
• Hospitals
• Diagnostic Imaging Centers
• Others
• Regional Outlook (Revenue, USD Million, 2018 - 2030)
• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
• Asia Pacific
  • Japan
  • China
  • India
  • Thailand
  • South Korea
  • Australia
• Latin America
  • Brazil
  • Argentina
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Market Definitions
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased Database
  • 1.4.2. GVR's Internal Database
• 1.5. Details of Primary Research
  • 1.5.1. Data for Primary Interviews in North America
  • 1.5.2. Data for Primary Interviews in Europe
  • 1.5.3. Data for Primary Interviews in Asia Pacific
  • 1.5.4. Data for Primary Interviews in Latin America
  • 1.5.5. Data for Primary Interviews in MEA
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Commodity Flow Analysis (Model 1)
    • 1.7.1.1. Approach 1: Commodity Flow Approach
  • 1.7.2. Volume price analysis (Model 2)
    • 1.7.2.1. Approach 2: Volume Price Analysis
• 1.8. Research Scope and Assumptions
  • 1.8.1. List of Secondary Sources
  • 1.8.2. List of Primary Sources
  • 1.8.3. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
• 2.3. Competitive Insights

Chapter 3. CT and MRI Contrast Agents Market Variables, Trends, & Scope

• 3.1. Market Introduction/Lineage Outlook
  • 3.1.1. Parent Market Outlook
  • 3.1.2. Related/Ancillary Market Outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Drivers Analysis
    • 3.2.1.1. Rising Prevalence of Chronic Disorders
    • 3.2.1.2. Technological Advancements
    • 3.2.1.3. Increasing Demand for Medical Imaging
    • 3.2.1.4. Rising Investment in Research & Development
  • 3.2.2. Market Restraints Analysis
    • 3.2.2.1. Side effects associated with contrast agents
  • 3.2.3. Market Opportunities Analysis
    • 3.2.3.1. Growing number of clinical trials
    • 3.2.3.2. Expansion opportunities in emerging markets
  • 3.2.4. Market Challenges Analysis
    • 3.2.4.1. Rising competition
• 3.3. CT and MRI Contrast Agents Market Analysis Tools
  • 3.3.1. Porter's Analysis
    • 3.3.1.1. Bargaining Power of the Suppliers
    • 3.3.1.2. Bargaining Power of the Buyers
    • 3.3.1.3. Threats of Substitution
    • 3.3.1.4. Threats From New Entrants
    • 3.3.1.5. Competitive Rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political Landscape
    • 3.3.2.2. Economic and Social Landscape
    • 3.3.2.3. Technological Landscape
    • 3.3.2.4. Environmental Landscape
    • 3.3.2.5. Legal Landscape

Chapter 4. CT and MRI Contrast Agents Market: Product Estimates & Trend Analysis

• 4.1. Definitions and Scope
• 4.2. Product Market Share, 2018 & 2030
• 4.3. Segment Dashboard
• 4.4. CT and MRI Contrast Agents Market by Product Outlook
• 4.5. Market Size & Forecasts and Trend Analysis, 2025 to 2030 for the following:
  • 4.5.1. Gadolinium-based Contrast Media
    • 4.5.1.1. Gadolinium-based contrast media market estimates and forecast 2018 to 2030 (USD Million)
  • 4.5.2. Iodinated Contrast Media
    • 4.5.2.1. Iodinated contrast media market estimates and forecast 2018 to 2030 (USD Million)

Chapter 5. CT and MRI Contrast Media Market: Modality Estimates & Trend Analysis

• 5.1. Definitions and Scope
• 5.2. Modality Market Share, 2024 & 2030
• 5.3. Segment Dashboard
• 5.4. CT and MRI Contrast Media Market by Modality Outlook
• 5.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 5.5.1. Magnetic Resonance Imaging
    • 5.5.1.1. Magnetic resonance imaging market estimates and forecast 2018 to 2030 (USD Million)
    • 5.5.1.2. Elucirem/Vueway
      • 5.5.1.2.1. Elucirem/Vueway market estimates and forecast 2018 to 2030 (USD Million)
    • 5.5.1.3. Dotarem
      • 5.5.1.3.1. Dotarem market estimates and forecast 2018 to 2030 (USD Million)
    • 5.5.1.4. ProHance
      • 5.5.1.4.1. ProHance market estimates and forecast 2018 to 2030 (USD Million)
    • 5.5.1.5. MultiHance
      • 5.5.1.5.1. MultiHance market estimates and forecast 2018 to 2030 (USD Million)
    • 5.5.1.6. Gadovist
      • 5.5.1.6.1. Gadovist market estimates and forecast 2018 to 2030 (USD Million)
    • 5.5.1.7. Eovist / Primovist
      • 5.5.1.7.1. Eovist / Primovist market estimates and forecast 2018 to 2030 (USD Million)
    • 5.5.1.8. Clariscan
      • 5.5.1.8.1. Clariscan market estimates and forecast 2018 to 2030 (USD Million)
    • 5.5.1.9. Other Generics
      • 5.5.1.9.1. Other generics market estimates and forecast 2018 to 2030 (USD Million)
  • 5.5.2. X-ray/Computed Tomography
    • 5.5.2.1. X-ray/computed tomography market estimates and forecast 2018 to 2030 (USD Million)
    • 5.5.2.2. Optiray
      • 5.5.2.2.1. Optiray market estimates and forecast 2018 to 2030 (USD Million)
    • 5.5.2.3. ISOVUE
      • 5.5.2.3.1. ISOVUE market estimates and forecast 2018 to 2030 (USD Million)
    • 5.5.2.4. Ultravist
      • 5.5.2.4.1. Ultravist market estimates and forecast 2018 to 2030 (USD Million)
    • 5.5.2.5. Omnipaque
      • 5.5.2.5.1. Omnipaque market estimates and forecast 2018 to 2030 (USD Million)
    • 5.5.2.6. Visipaque
      • 5.5.2.6.1. Visipaque market estimates and forecast 2018 to 2030 (USD Million)
    • 5.5.2.7. Other Generics
      • 5.5.2.7.1. Other generics market estimates and forecast 2018 to 2030 (USD Million)

Chapter 6. CT and MRI Contrast Media Market: Application Estimates & Trend Analysis

• 6.1. Definitions and Scope
• 6.2. Application Market Share, 2024 & 2030
• 6.3. Segment Dashboard
• 6.4. CT and MRI Contrast Media Market by Application Outlook
• 6.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 6.5.1. Cardiovascular Disorders
    • 6.5.1.1. Cardiovascular disorders market estimates and forecast 2018 to 2030 (USD Million)
  • 6.5.2. Neurological Disorders
    • 6.5.2.1. Neurological disorders market estimates and forecast 2018 to 2030 (USD Million)
  • 6.5.3. Gastrointestinal Disorders
    • 6.5.3.1. Gastrointestinal disorders market estimates and forecast 2018 to 2030 (USD Million)
  • 6.5.4. Cancer
    • 6.5.4.1. Cancer market estimates and forecast 2018 to 2030 (USD Million)
  • 6.5.5. Nephrological Disorders
    • 6.5.5.1. Nephrological disorders market estimates and forecast 2018 to 2030 (USD Million)
  • 6.5.6. Musculoskeletal Disorders
    • 6.5.6.1. Musculoskeletal disorders market estimates and forecast 2018 to 2030 (USD Million)
  • 6.5.7. Others
    • 6.5.7.1. Others market estimates and forecast 2018 to 2030 (USD Million)

Chapter 7. CT and MRI Contrast Media Market: Route of Administration Estimates & Trend Analysis

• 7.1. Definitions and Scope
• 7.2. Route of Administration Market Share, 2024 & 2030
• 7.3. Segment Dashboard
• 7.4. CT and MRI Contrast Media Market by Route of Administration Outlook
• 7.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 7.5.1. Intravenous
    • 7.5.1.1. Intravenous contrast media market estimates and forecast 2018 to 2030 (USD Million)
  • 7.5.2. Oral Contrast Media
    • 7.5.2.1. Oral contrast media market estimates and forecast 2018 to 2030 (USD Million)
  • 7.5.3. Rectal
    • 7.5.3.1. Rectal contrast media market estimates and forecast 2018 to 2030 (USD Million)

Chapter 8. CT and MRI Contrast Media Market: End Use Estimates & Trend Analysis

• 8.1. Definitions and Scope
• 8.2. End Use Market Share, 2024 & 2030
• 8.3. Segment Dashboard
• 8.4. CT and MRI Contrast Media Market by End Use Outlook
• 8.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 8.5.1. Hospitals
    • 8.5.1.1. Hospitals market estimates and forecast 2018 to 2030 (USD Million)
  • 8.5.2. Diagnostic Imaging Centers
    • 8.5.2.1. Diagnostic imaging centers market estimates and forecast 2018 to 2030 (USD Million)
  • 8.5.3. Others
    • 8.5.3.1. Others market estimates and forecast 2018 to 2030 (USD Million)

Chapter 9. CT and MRI Contrast Agents Market: Regional Estimates & Trend Analysis, By Product

• 9.1. Regional market share analysis, 2024 & 2030
• 9.2. Regional Market Dashboard
• 9.3. Global Regional Market Snapshot
• 9.4. Regional Market Share and Leading Players, 2024
  • 9.4.1. North America
  • 9.4.2. Europe
  • 9.4.3. Asia Pacific
  • 9.4.4. Latin America
  • 9.4.5. Middle East and Africa
• 9.5. Market Size & Forecasts, and Trend Analysis, 2018 to 2030
• 9.6. CT and MRI Contrast Agents Market Share, By Region, 2024 & 2030 (USD Million)
• 9.7. North America
  • 9.7.1. North America CT and MRI Contrast Agents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 9.7.2. U.S.
    • 9.7.2.1. Key Country Dynamics
    • 9.7.2.2. Competitive Scenario
    • 9.7.2.3. Regulatory Framework
    • 9.7.2.4. Reimbursement Scenario
    • 9.7.2.5. U.S. Market Estimates and Forecasts, 2018 - 2030
  • 9.7.3. Canada
    • 9.7.3.1. Key Country Dynamics
    • 9.7.3.2. Competitive Scenario
    • 9.7.3.3. Regulatory Framework
    • 9.7.3.4. Reimbursement Scenario
    • 9.7.3.5. Canada Market Estimates and Forecasts, 2018 - 2030
  • 9.7.4. Mexico
    • 9.7.4.1. Key Country Dynamics
    • 9.7.4.2. Competitive Scenario
    • 9.7.4.3. Regulatory Framework
    • 9.7.4.4. Reimbursement Scenario
    • 9.7.4.5. Mexico Market Estimates and Forecasts, 2018 - 2030
• 9.8. Europe
  • 9.8.1. Europe CT and MRI Contrast Agents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 9.8.2. UK
    • 9.8.2.1. Key Country Dynamics
    • 9.8.2.2. Competitive Scenario
    • 9.8.2.3. Regulatory Framework
    • 9.8.2.4. Reimbursement Scenario
    • 9.8.2.5. UK Market Estimates and Forecasts, 2018 - 2030
  • 9.8.3. Germany
    • 9.8.3.1. Key Country Dynamics
    • 9.8.3.2. Competitive Scenario
    • 9.8.3.3. Regulatory Framework
    • 9.8.3.4. Reimbursement Scenario
    • 9.8.3.5. Germany Market Estimates and Forecasts, 2018 - 2030
  • 9.8.4. France
    • 9.8.4.1. Key Country Dynamics
    • 9.8.4.2. Competitive Scenario
    • 9.8.4.3. Regulatory Framework
    • 9.8.4.4. Reimbursement Scenario
    • 9.8.4.5. France Market Estimates and Forecasts, 2018 - 2030
  • 9.8.5. Italy
    • 9.8.5.1. Key Country Dynamics
    • 9.8.5.2. Competitive Scenario
    • 9.8.5.3. Regulatory Framework
    • 9.8.5.4. Reimbursement Scenario
    • 9.8.5.5. Italy Market Estimates and Forecasts, 2018 - 2030
  • 9.8.6. Spain
    • 9.8.6.1. Key Country Dynamics
    • 9.8.6.2. Competitive Scenario
    • 9.8.6.3. Regulatory Framework
    • 9.8.6.4. Reimbursement Scenario
    • 9.8.6.5. Spain Market Estimates and Forecasts, 2018 - 2030
  • 9.8.7. Denmark
    • 9.8.7.1. Key Country Dynamics
    • 9.8.7.2. Competitive Scenario
    • 9.8.7.3. Regulatory Framework
    • 9.8.7.4. Reimbursement Scenario
    • 9.8.7.5. Denmark Market Estimates and Forecasts, 2018 - 2030
  • 9.8.8. Sweden
    • 9.8.8.1. Key Country Dynamics
    • 9.8.8.2. Competitive Scenario
    • 9.8.8.3. Regulatory Framework
    • 9.8.8.4. Reimbursement Scenario
    • 9.8.8.5. Sweden Market Estimates and Forecasts, 2018 - 2030
  • 9.8.9. Norway
    • 9.8.9.1. Key Country Dynamics
    • 9.8.9.2. Competitive Scenario
    • 9.8.9.3. Regulatory Framework
    • 9.8.9.4. Reimbursement Scenario
    • 9.8.9.5. Norway Market Estimates and Forecasts, 2018 - 2030
• 9.9. Asia Pacific
  • 9.9.1. Asia Pacific CT and MRI Contrast Agents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 9.9.2. China
    • 9.9.2.1. Key Country Dynamics
    • 9.9.2.2. Competitive Scenario
    • 9.9.2.3. Regulatory Framework
    • 9.9.2.4. Reimbursement Scenario
    • 9.9.2.5. China Market Estimates and Forecasts, 2018 - 2030
  • 9.9.3. India
    • 9.9.3.1. Key Country Dynamics
    • 9.9.3.2. Competitive Scenario
    • 9.9.3.3. Regulatory Framework
    • 9.9.3.4. Reimbursement Scenario
    • 9.9.3.5. India Market Estimates and Forecasts, 2018 - 2030
  • 9.9.4. Japan
    • 9.9.4.1. Key Country Dynamics
    • 9.9.4.2. Competitive Scenario
    • 9.9.4.3. Regulatory Framework
    • 9.9.4.4. Reimbursement Scenario
    • 9.9.4.5. Japan Market Estimates and Forecasts, 2018 - 2030
  • 9.9.5. South Korea
    • 9.9.5.1. Key Country Dynamics
    • 9.9.5.2. Competitive Scenario
    • 9.9.5.3. Regulatory Framework
    • 9.9.5.4. Reimbursement Scenario
    • 9.9.5.5. South Korea Market Estimates and Forecasts, 2018 - 2030
  • 9.9.6. Thailand
    • 9.9.6.1. Key Country Dynamics
    • 9.9.6.2. Competitive Scenario
    • 9.9.6.3. Regulatory Framework
    • 9.9.6.4. Reimbursement Scenario
    • 9.9.6.5. Thailand Market Estimates and Forecasts, 2018 - 2030
  • 9.9.7. Australia
    • 9.9.7.1. Key Country Dynamics
    • 9.9.7.2. Competitive Scenario
    • 9.9.7.3. Regulatory Framework
    • 9.9.7.4. Reimbursement Scenario
    • 9.9.7.5. Australia Market Estimates and Forecasts, 2018 - 2030
• 9.10. Latin America
  • 9.10.1. Latin America CT and MRI Contrast Agents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 9.10.2. Brazil
    • 9.10.2.1. Key Country Dynamics
    • 9.10.2.2. Competitive Scenario
    • 9.10.2.3. Regulatory Framework
    • 9.10.2.4. Reimbursement Scenario
    • 9.10.2.5. Brazil Market Estimates and Forecasts, 2018 - 2030
  • 9.10.3. Argentina
    • 9.10.3.1. Key Country Dynamics
    • 9.10.3.2. Competitive Scenario
    • 9.10.3.3. Regulatory Framework
    • 9.10.3.4. Reimbursement Scenario
    • 9.10.3.5. Argentina Market Estimates and Forecasts, 2018 - 2030
• 9.11. Middle East and Africa
  • 9.11.1. Middle East and Africa CT and MRI Contrast Agents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 9.11.2. South Africa
    • 9.11.2.1. Key Country Dynamics
    • 9.11.2.2. Competitive Scenario
    • 9.11.2.3. Regulatory Framework
    • 9.11.2.4. Reimbursement Scenario
    • 9.11.2.5. South Africa Market Estimates and Forecasts, 2018 - 2030
  • 9.11.3. Saudi Arabia
    • 9.11.3.1. Key Country Dynamics
    • 9.11.3.2. Competitive Scenario
    • 9.11.3.3. Regulatory Framework
    • 9.11.3.4. Reimbursement Scenario
    • 9.11.3.5. Saudi Arabia Market Estimates and Forecasts, 2018 - 2030
  • 9.11.4. UAE
    • 9.11.4.1. Key Country Dynamics
    • 9.11.4.2. Competitive Scenario
    • 9.11.4.3. Regulatory Framework
    • 9.11.4.4. Reimbursement Scenario
    • 9.11.4.5. UAE Market Estimates and Forecasts, 2018 - 2030
  • 9.11.5. Kuwait
    • 9.11.5.1. Key Country Dynamics
    • 9.11.5.2. Competitive Scenario
    • 9.11.5.3. Regulatory Framework
    • 9.11.5.4. Reimbursement Scenario
    • 9.11.5.5. Kuwait Market Estimates and Forecasts, 2018 - 2030

Chapter 10. Competitive Landscape

• 10.1. Recent Developments & Impact Analysis, By Key Market Participants
• 10.2. Company/Competition Categorization
• 10.3. Vendor Landscape
  • 10.3.1. List of key distributors
  • 10.3.2. Key Company Market Share Analysis, 2024
• 10.4. Key Company Profiles
  • 10.4.1. Bayer
    • 10.4.1.1. Company overview
    • 10.4.1.2. Financial performance
    • 10.4.1.3. Product benchmarking
    • 10.4.1.4. Strategic initiatives
  • 10.4.2. GE Healthcare
    • 10.4.2.1. Company overview
    • 10.4.2.2. Financial performance
    • 10.4.2.3. Product benchmarking
    • 10.4.2.4. Strategic initiatives
  • 10.4.3. Guerbet
    • 10.4.3.1. Company overview
    • 10.4.3.2. Financial performance
    • 10.4.3.3. Product benchmarking
    • 10.4.3.4. Strategic initiatives
  • 10.4.4. Bracco Diagnostics Inc
    • 10.4.4.1. Company overview
    • 10.4.4.2. Financial performance
    • 10.4.4.3. Product benchmarking
    • 10.4.4.4. Strategic initiatives
  • 10.4.5. Fresenius Kabi
    • 10.4.5.1. Company overview
    • 10.4.5.2. Financial performance
    • 10.4.5.3. Product benchmarking
    • 10.4.5.4. Strategic initiatives